0001944095-25-000002.txt : 20251020 0001944095-25-000002.hdr.sgml : 20251020 20251020141943 ACCESSION NUMBER: 0001944095-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251020 DATE AS OF CHANGE: 20251020 EFFECTIVENESS DATE: 20251020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MOAT BIOTECHNOLOGY Corp CENTRAL INDEX KEY: 0001944095 ORGANIZATION NAME: EIN: 882958288 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561383 FILM NUMBER: 251403375 BUSINESS ADDRESS: STREET 1: 840 RESEARCH PARKWAY SUITE 516 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 BUSINESS PHONE: (405) 271-1469 MAIL ADDRESS: STREET 1: 840 RESEARCH PARKWAY SUITE 516 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 D 1 primary_doc.xml X0708 D LIVE 0001944095 MOAT BIOTECHNOLOGY Corp 5501 White Fences Road OKLAHOMA CITY OK OKLAHOMA 73131 (405) 271-1469 DELAWARE MOAT Vaccine Technology Corporation None Limited Liability Company true 2022 Scott A. Rollins 5501 White Fences Road Oklahoma City OK OKLAHOMA 73131 Executive Officer Director Promoter Russell P. Rother 669 Meadowbrook Circle Steamboat Springs CO COLORADO 80487 Executive Officer Director Promoter Phillip Jones 1125 N. Porter Avenue, Suite 205 Norman OK OKLAHOMA 73071 Director Todd Foley 2150 Rapid Creek Road Alta WY WYOMING 83141 Director Tetherex Pharmaceuticals Corporation 5501 White Fences Road Oklahoma City OK OKLAHOMA 73131 Promoter Michael Moradi-Araghi 12 E. California, Suite 200 Oklahoma City OK OKLAHOMA 73104 Director Biotechnology No Revenues 06b false 2025-10-03 false true false 26400 15593738 26400 15567338 false 1 0 true 800000 true The Corporation has retained a finder who may receive finders' fees. The maximum expected finders' fee is $800,000. 4500000 true Tetherex provides employees & certain services pursuant to that certain Administrative Services Agreement & that certain Research Services Agreement, both by & between Tetherex Pharmaceuticals Corporation & MOAT Biotechnology Corporation, dated 9/6/2022 false MOAT BIOTECHNOLOGY Corp Scott A. Rollins Scott A. Rollins CEO 2025-10-20